Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.
NCT ID: NCT01059058
Last Updated: 2015-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
240 participants
INTERVENTIONAL
2010-03-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluoride Varnish for Treatment of White Spot Lesions
NCT01500187
Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment
NCT05733676
RMGI Varnish Versus APF Gel in Prevention of White Spot Lesions During Orthodontic Treatment
NCT03721198
Orthodontic Varnish Microbiology Study
NCT04528134
MI Varnish for the Prevention of White Spot Lesions
NCT03446690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) containing products are a recently proposed therapy for the treatment of white spots following orthodontic treatment. CPP is thought to stabilize and localize calcium, fluoride, and phosphate at the tooth surface in a slow-release amorphous form, thus enhancing deeper remineralization of WSL. Products containing CPP-ACP are currently marketed under various names, including MI Paste Plus (which also contains fluoride). Few in vivo studies have investigated the effectiveness of various remineralization products to address WSL after orthodontics. This project is a single-blind, randomized clinical trial with three arms - MI Paste Plus for an 8-week duration, a single application of Duraphat Fluoride Varnish with reassessment at 8 weeks, and normal home care for an 8 week period. Subjects will be recruited at their regularly scheduled orthodontic appointments, with eligible subjects being up to 2 years post-removal of fixed orthodontic appliances.
This project is intended to answer four questions regarding the management of white spot lesions.
Specific Aim 1: to compare the effectiveness MI Paste Plus and Duraphat Fluoride Varnish to a standard oral hygiene/toothpaste regimen in improving the appearance of WSL after orthodontic treatment.
Specific Aim 2: to investigate subjects' self-assessment of improvement in each of the three arms.
Specific Aim 3: to investigate variables (such as age, gender, time since fixed orthodontic appliance removal, compliance, oral hygiene practices, etc) that may influence WSL improvement.
Specific Aim 4: to investigate the short-term changes in WSL from the day of orthodontic appliance removal until the day of retainer delivery (usually 2 - 7 days).
This study will provide valuable evidence on the management of WSL after orthodontic treatment. As previously stated, WSL lesions are quite common and difficult to reverse, so it is important to conduct rigorous clinical research in an effort to develop effective strategies.
This study will be a randomized clinical trial. NW PRECEDENT providers will invite subjects to participate if they are between the ages of 12 and 20 and have at least one new WSL on the 4 maxillary incisors associated with orthodontic treatment. These are the most common teeth to develop these lesions. The NW PRECEDENT provider must verify that the WSL were not present in the pre-orthodontic treatment records. Subjects must be willing to be placed into any of the following three groups:
1. Test Group A: 10% CPP-ACP + 900 ppm Fluoride paste - a trained staff member from the NW PRECEDENT dental/orthodontic office will give 3 tubes of MI Paste Plus and instructions to the subject for home use. The subjects will also receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The group will consist of 80 subjects, and each subject will be given enough MI Paste for the duration of the trial. Treatment will begin on the day of retainer delivery if the subject was recruited on the day of fixed appliance removal. Otherwise, the treatment will begin on the date of recruitment.
2. Test Group B: Fluoride Varnish Group - a trained staff member from the NW PRECEDENT dental/orthodontic office will provide a single fluoride varnish application (22,600 ppm Fluoride) to the subject. The subjects will also receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The group will consist of 80 subjects. Treatment will begin on the day of retainer delivery if the subject was recruited on the day of fixed appliance removal. Otherwise, the treatment will begin on the date of recruitment.
3. Control Group - These 80 subjects will receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions at the time of enrollment. After the trial is completed (\~ August 2011), these subjects will be informed of the results, and offered one of the two active arms, if they are found to be effective in reducing WSL.
The NW PRECEDENT provider and the subject will also fill out a short survey to compile information about the subject's age, gender, race, ethnicity, time in fixed appliances, oral hygiene during treatment, and type of retainers after orthodontic treatment. Upon determining a subject's eligibility and willingness to participate, as well as obtaining assent/consent, he/she will be randomly assigned to a group, a baseline photograph will be taken, and the assigned treatment will begin. In the case of subjects who have just had their orthodontic appliances removed, the subjects will undergo enrollment and photos, but their assigned treatment will not begin until the day of retainer delivery. The subject's general dentist (if they did not perform their orthodontic care) will be sent a letter informing them that their patients are currently enrolled in the study, and that any additional treatment for white spot lesions should be delayed until the study is complete (8 weeks).
Subjects who are identified at some time after their fixed orthodontic appliances have been removed will have baseline photographs taken on the day of recruitment. Subjects who are identified on the day their appliances are removed will have photographs taken on that day, as well at the time of retainer delivery (2 - 7 days later). A subsequent analysis of the day of fixed appliance removal and one week follow-up photographs will be performed, in order to determine if significant changes are evident during this short period immediately after fixed appliance removal. This is being investigated because portions of the teeth under the braces have been shielded from the oral cavity for several years, and they may also have been desiccated during the removal of braces. Additionally, the gums may be puffy and swollen immediately after taking braces off, and parts of the teeth may not be visible. The photographs will be sent to the online data capture system.
At the eight-week time point, NW PRECEDENT providers will recall the subjects (240 total) and take the eight-week follow-up photographs in the same standardized format as the baseline photographs. The photographs will be sent via the online data capture system. The NW PRECEDENT provider will administer an in office survey to the subject to gather information regarding satisfaction with using the treatment, compliance, oral hygiene practices, and self-assessment of improvement of the WSL.
A group of blinded examiners consisting of five to ten laypersons and five to ten dental experts will view each subject's set of digital photographs in chronological order on a PowerPoint presentation. The photographs will only show the four maxillary incisor teeth and will be unidentifiable to the examiners. Each set of photographs will then be given an improvement rating on a 100 mm visual analog scale (VAS) (0=no improvement, 100=100% improvement). In addition, both a graduate orthodontic resident and a dental student will blindly assess the digital photographs by measuring the size of the white spot lesion relative to the rest of the tooth expressed as a percent. Statistical analysis will then be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Group A: MI Paste Plus Group
MI Paste Plus
A trained staff member from the NW PRECEDENT dental/orthodontic office will give 3 tubes of MI Paste Plus (10% CPP-ACP + 900 ppm Fluoride paste) and instructions to the subject for home use. A pea-sized amount for each arch will be applied 2x/day for 8 weeks. Subjects will apply cream topically to the teeth with their finger or a cotton swab, spread around with their tongue, hold for 1-2 minutes, then expectorate.
Normal Home Care
Subjects will receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The dosage will be 1/2 inch strip of paste 2x/day for 8 weeks. Subjects will apply paste to a toothbrush and brush teeth thoroughly for at least 1 minute then expectorate.
Test Group B: Fluoride Varnish Group
PreviDent Fluoride Varnish
A trained staff member from the NW PRECEDENT dental/orthodontic office will provide a SINGLE application of PreviDent fluoride varnish (22,600 ppm Fluoride) to the subject. The total dosage will be 0.5 mL.
Normal Home Care
Subjects will receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The dosage will be 1/2 inch strip of paste 2x/day for 8 weeks. Subjects will apply paste to a toothbrush and brush teeth thoroughly for at least 1 minute then expectorate.
Control Group
Normal Home Care
Subjects will receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The dosage will be 1/2 inch strip of paste 2x/day for 8 weeks. Subjects will apply paste to a toothbrush and brush teeth thoroughly for at least 1 minute then expectorate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MI Paste Plus
A trained staff member from the NW PRECEDENT dental/orthodontic office will give 3 tubes of MI Paste Plus (10% CPP-ACP + 900 ppm Fluoride paste) and instructions to the subject for home use. A pea-sized amount for each arch will be applied 2x/day for 8 weeks. Subjects will apply cream topically to the teeth with their finger or a cotton swab, spread around with their tongue, hold for 1-2 minutes, then expectorate.
PreviDent Fluoride Varnish
A trained staff member from the NW PRECEDENT dental/orthodontic office will provide a SINGLE application of PreviDent fluoride varnish (22,600 ppm Fluoride) to the subject. The total dosage will be 0.5 mL.
Normal Home Care
Subjects will receive non-prescription fluoride toothpaste (1100 ppm Fluoride) and oral hygiene instructions. The dosage will be 1/2 inch strip of paste 2x/day for 8 weeks. Subjects will apply paste to a toothbrush and brush teeth thoroughly for at least 1 minute then expectorate.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least one white spot lesion on the facial surface of a maxillary central or lateral incisor tooth that was not present prior to treatment with fixed orthodontic appliances.
* Between the ages of 12 and 20 years of age
* Agrees to randomization to the different treatment protocols
* Signed informed consent obtained from a parent or guardian of the patient f the patient is under the age of eighteen
Exclusion Criteria
* Any abnormal oral, medical, or mental conditions, including any milk-related allergies and/or any medical conditions involving the kidneys.
* Any patients who underwent therapy for white spot lesion after completion of orthodontic treatment
* Any white spot lesion present on qualifying teeth with frank cavitation
* Patient is non-English speaking or non-English reading
12 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pacific NW Dental Practice-Based Research Network
NETWORK
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Greg Huang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Greg H Huang, DMD,MSD,MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington/NW PRECEDENT
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37062-E/B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.